Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 65INDUSTRY 23NIH 5OTHER_GOV 2NETWORK 1INDIV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Autologous Stem Cell Transplantation 1

Interventions

Cisplatin 48Capecitabine 41Gemcitabine 33apatinib 32Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Nivolumab 17pembrolizumab 16Surgical Procedures, Operative 16Exercise 16Metformin 15S 1 (combination) 14camrelizumab 13Radiation 13Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11Vinorelbine 10Standard of Care 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × plerixafor × Clear all
NCT01164345 2015-12-03

Mozobil for Autologous Stem Cell Mobilization

Sheba Medical Center

Phase 2 Completed
20 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT02006225 2013-12-10

GCSF

Tel-Aviv Sourasky Medical Center

Phase 4 Unknown
30 enrolled

Autologous Stem Cell Transplantation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡